|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 家庭锻炼对跌倒后的高危社区老年人后续跌倒的影响:一项随机临床试验显示文摘锻炼是否减少已经历跌倒的高风险老年人后续发生跌倒的风险尚不清楚。为评估家庭锻炼计划被转诊到跌倒预防诊所的老年人再发生跌倒风险的效果,本研究在2009年4月22日至2018年6月5日期间,在过去12个月内发生过跌倒的70岁以上的人群中招募研究对象进行为期12个月的单盲随机临床试验,参与者被随机分配到干预组和常规护理组,干预组(n=173)接受常规护理和物理治疗师提供的家庭力量和平衡再训练计划,常规护理组(n=172)接受老年病医生提供的防跌护理。 | Liu-Ambrose T Davis JC Best JR 袁淑娟(编译) 胡国清(编译) | 2019 | 中华预防医学杂志2019，53，9： | 8 |
| 2 | Recombinant human tumor necrosis factor receptor (etanercept)for treating ankylosing spondylitis:a randomized,controlled trial显示文摘 | Van Der Heijde D Braun J | 2003 | Arthritis Rheum2003，48，： | 1 |
| 3 | Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis:a randomized,controlled trial显示文摘 | Davis JC Jr Van Der Heijde D Braun J | 2003 | Arthritis Rheum2003，48，11： | 1 |
| 4 | Treatment of systemic lupus erythenmtosus by inhibition of T cell costimulation with anti -CD 154 : a randomized, double-blind, placebo- controlled trial 显示文摘 | Kalunian KC Davis JC Jr Merrill JT | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 5 | Baseline fac-tors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept 显示文摘 | Davis JC Jr van der Heijde DM Dougados M | 2005 | J Rheumatol2005，32，9： | 1 |
| 6 | Treatment of ankylos- ing spondylitis by inhibition of tumor necrosis factor al- pha 显示文摘 | Gorman JD Sack KE Davis JC Jr | 2002 | The New England Journal of Medicine2002，346，18： | 1 |
| 7 | Recombinant human tumor necrosis factor receptor (etanercept)for treating ankylosing spondylitis:a randomized,controlled trial显示文摘 | Van Der Heijde D Braun J | 2003 | Arthritis Rheum2003，48，： | 1 |
| 8 | Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis显示文摘 | DAVIS JC JR | 2005 | Semin Arthritis Rheum2005，34，4： | 1 |
| 9 | Gd-DTPA and MR imaging of pituitary adenoma:apreliminary report显示文摘 | Davis PC Hoffman JC Jr Malko JA | 1987 | AJNR1987，8，： | 1 |
| 10 | Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection显示文摘 | Williams JR Jordan JC Davis EA | 2007 | Sex Transm Dis2007，34，3： | 1 |
| 11 | Reconmbinant human tumor necrosis factor receptor (etanereept) for treating ankylosing spondylitis 显示文摘 | Davis JC Jr | 2003 | Arthritis Rheum2003，48，： | 1 |
| 12 | Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept显示文摘 | Davis JC Jr Van der Heijde DM Dougados M | 2005 | J Rheumatol2005，32，9： | 1 |
| 13 | A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults 显示文摘 | Oxman MN Levin MJ Johnson GR Schmader KE Straus SE Gelb LD Arbeit RD Simberkoff MS Gershon AA Davis LE Weinberg A Boardman KD Williams HM Zhang JH Peduzzi PN Beisel CE Morrison VA Guatelli JC Brooks PA Kauffman CA Pachucki CT Neuzil KM Betts RF Wright PF Griffin MR Brunell P Soto NE Marques AR Keay SK Goodman RP Cotton DJ Gnann JW Jr Loutit J Holodniy M Keitel WA Crawford GE Yeh SS Lobo Z Toney JF Greenberg RN Keller PM Harbecke R Hayward AR Irwin MR Kyriakides TC Chan CY Chan IS Wang WW Annunziato PW Silber JL Shingles Prevention Study Group | 2005 | New Engl J Med2005，352，22： | 1 |
| 14 | Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti CD154: a randomized, double-blind, placebo controlled trial 显示文摘 | Kalunian KC Davis JC Jr Merrill JT | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 15 | Gender and histologic type variations in smoking-related risk of lung cancer显示文摘 | Brownson RC Chang JC Davis JR | 1992 | Epidemiology1992，3，： | 1 |
| 16 | Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis显示文摘 | Davis JC Jr | 2005 | Semin Arthritis Rheum2005，34，4： | 1 |
| 17 | Gender and histologic type variations in smoking-related risk of lung cancer显示文摘 | Brownson RC Chang JC Davis JR | 1992 | Epidemiology1992，3，1： | 1 |
| 18 | Efficacy and safe- ty of golimumab in patients with ankylosing spondylitis: re- sults of a randomized, double-blind, placebo-controlled, phase III trial 显示文摘 | Inman RD Davis JC Jr Heijde D | 2008 | Arthritis Rheum2008，58，11： | 1 |
| 19 | Recombinant human tumor necrosis factor receptor (etanereept) for treating ankylosing spondylitis: a randomized; controlled trial 显示文摘 | Davis JC Jr van der tteijde D Braun J | 2003 | Arthritis Rheum2003，48，： | 1 |
| 20 | Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis显示文摘 | Davis JC Jr van der Heijde DM Braun J | 2008 | Ann Rheum Dis2008，67，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员